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The receptor binding domain of the tailspike protein Gp9 from the P22 bacteriophage
was recently shown to reduce Salmonella colonization in the chicken gut. In this study,
we transiently expressed the receptor binding domain of the Gp9 tailspike protein
in Nicotiana benthamiana, and targeted it to the endoplasmic reticulum (ER) or to
the chloroplasts. Gp9 was also fused to either an elastin-like polypeptide (ELP) or
hydrophobin I tag, which were previously described to improve accumulation levels of
recombinant proteins. The highest levels of recombinant protein accumulation occurred
when unfused Gp9 was targeted to the ER. Lower levels of chloroplast-targeted
Gp9 were also detected. ELP-fused Gp9 was purified and demonstrated to bind to
Salmonella enterica serovar Typhimurium in vitro. Upon oral administration of lyophilized
leaves expressing Gp9-ELP to newly hatched chickens, we found that this tailspike
protein has the potential to be used as a therapeutic to control Salmonella contamination
in chickens.
Keywords: bacteriophage tailspike protein, chickens, Nicotiana benthamiana, plant biotechnology, Salmonella,
transient transformation
INTRODUCTION
The human intestine is a complex microbial ecosystem where hundreds of species of bacteria
have adapted to live and grow. A mutualistic relationship has evolved beneﬁting the health of the
host while providing an optimal habitat for microﬂora to thrive (Guarner and Malagelada, 2003).
However, some of these bacteria are pathogenic, causing a wide array of intestinal pathologies.
Salmonella enterica is a Gram-negative enteropathogenic bacterium that is widely prevalent and is
one of the primary causes of foodborne illness in humans. There are roughly 1.4 million non-
typhoidal salmonellosis cases each year in North America, causing approximately 25% of all
hospitalizations due to foodborne illness (Mead et al., 1999). S. enterica serotype Typhimurium
also referred to as S. Typhimurium, causes gastroenteritis characterized by diarrhea, vomiting,
and abdominal pain and is showing the emergence of multidrug-resistant strains (Su et al., 2004;
Abbreviations: BSA, bovine serum albumin; CFU, colony-forming units; ELP, synthetic elastin-like polypeptide; ER,
endoplasmic reticulum; FLW, fresh leaf weight; GI tract, gastro-intestinal tract; HFBI, hydrophobin I from Trichoderma
reesei; S. Typhimurium, Salmonella enterica serovar Typhimurium; S. Paratyphi, Salmonella enterica serovar Paratyphi;
S. Enteritidis, Salmonella enterica serovar Enteriditis; S.Heidelberg, SalmonellaHeidelberg; TSP, total soluble protein(s).
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Chen et al., 2013). Poultry and eggs are a major source of
infection, but other sources such as vegetables, fruits, nuts,
sprouts, leafy greens, roots, and beans have been reported
(Rodrigue et al., 1990; Hammack, 2012). In chickens, Salmonella
is found throughout the intestinal tract (Fanelli et al., 1971)
and the rupturing of intestinal contents during evisceration can
readily contaminate poultry meat. For instance, Salmonella has
been isolated from 33% of raw chicken breasts sampled from
retail grocery stores in Ontario, Canada (Cook et al., 2012).
Antibiotic use has led to the emergence of antibiotic-
resistant Salmonella strains. In 2013, 17% of typhoidal Salmonella
isolates from Canadians were resistant to ciproﬂoxacin and
41% of S. Heidelberg infections were resistant to at least
one antibiotic1. This growing concern has provoked research
into alternative methods for controlling bacterial outbreaks.
Considerable research into using bacteriophage therapy to
treat or prevent bacterial infections progressed in Eastern
Europe and the former Soviet Union during the latter part of
the 20th century and could potentially be reconsidered as a
viable alternative to antibiotics (Sulakvelidze et al., 2001). Lytic
bacteriophages are host-speciﬁc, self-replicating, and virtually
non-toxic making them attractive alternatives to control bacteria
such as Salmonella and bacteriophages have been shown to
reduce Salmonella colonization in chickens (Goode et al., 2003;
Atterbury et al., 2007). Despite these successes, this therapy is not
without drawbacks. Bacteriophages are host-speciﬁc requiring
diagnosis of the pathogen before the phage is administered
(Waseh et al., 2010). Phages can also carry harmful genes and
can potentially transfer these genes to the bacteria, increasing
virulence (Skurnik and Strauch, 2006). As a result, there has
been interest in the use of phage proteins such as endolysins
(Roach and Donovan, 2015) as tools for the speciﬁc targeting of
bacteria and the exploitation of phage receptor binding proteins
for use in diagnostics and engineered phage-derived killing
machines (Singh et al., 2012; Simpson et al., 2015). Unexpectedly,
Waseh et al. (2010) have demonstrated that the P22 phage
tailspike protein alone is eﬀective in controlling Salmonella
colonization and spread in chickens, presumably through its
binding capability. These tailspike proteins are highly stable
homotrimers that form the short tail of the bacteriophage and
bind to the O-antigenic repeating units on the outer membrane
lipopolysaccharide (Baxa et al., 1996). The tailspike protein Gp9
from the P22 bacteriophage can recognize several serovars of
Salmonella including S. Typhimurium, S. Paratyphi A, and S.
Enteritidis. A shortened version of Gp9 has been shown to
agglutinate S.Typhimurium, inhibit bacterial motility and reduce
colonization in the chicken gut (Waseh et al., 2010). Therefore,
this protein has the potential to act as an eﬀective pre-slaughter
feed additive to reduce Salmonella contamination in chickens.
Plant bioreactors have been growing in acceptance as feasible
production platforms for therapeutic proteins, as they are
highly scalable and can be established with little upfront
cost (Fischer et al., 2012). Protein drugs expressed in plant
1http://healthycanadians.gc.ca/alt/pdf/publications/drugs-products-medicaments-
produits/antibiotic-resistance-antibiotique/antimicrobial-surveillance-antimicro
bioresistance-eng.pdf
tissue are thought to be protected from digestive enzymes
by the plant cell wall (Kwon and Daniell, 2015), and are
especially useful for veterinary applications where regulations
allow administration of unpuriﬁed or partially puriﬁed extracts
(MacDonald et al., 2015). For example, leaf tissue can be
harvested, lyophilized, and orally administered in capsules or
suspended in a slurry removing costs associated with protein
puriﬁcation, administration, and cold-storage (Kolotilin et al.,
2014). As higher eukaryotic organisms, plants can introduce post-
translational modiﬁcations required for complex recombinant
proteins. Despite these beneﬁts, recombinant protein yield
remains a major factor limiting the widespread adoption of plant
bioreactors for commercial protein production. Consequently,
several approaches are currently being used to increase protein
accumulation in plants. Proteins can be targeted to diﬀerent
subcellular compartments such as the ER, the chloroplasts, and
the apoplast using signal and transit peptides (Conley et al.,
2009b). This is because each subcellular compartment has a
unique biochemical environment, protease content, and physical
size which inﬂuence protein accumulation levels (Streatﬁeld,
2007; Pillay et al., 2014). Additionally, peptide tags can be fused
to recombinant protein to increase accumulation. For example,
fusion tags such as ELPs and HFBI can increase recombinant
protein accumulation levels, and have also been used to purify
proteins from plant extracts (Conley et al., 2011).
The goal of this project was to transiently produce the
truncated version of Gp9 in Nicotiana benthamiana by targeting
the protein to the chloroplasts, to the ER, or to the ER fused with
an ELP or HFBI tag. The activity of plant-produced Gp9 was
then tested by examining its ability to bind to S. Typhimurium.
Lastly, plant tissue containing Gp9 was orally administered to
chickens inoculated with S. Typhimurium to determine if this
plant produced therapeutic has the potential to limit Salmonella
colonization.
MATERIALS AND METHODS
Gene Cloning
The truncated version (encoding amino acids 109–666) of
the endorhamnosidase mutant of gp9 (as described in Waseh
et al., 2010) was codon-optimized for plant expression and
synthesized by Biobasic Inc. (Markham, ON, Canada). Gp9
was recombined into the previously constructed pCaMGate
expression vectors using the LR reaction of Gateway R© technology
(Thermo Fischer Scientiﬁc, Waltham, MA, USA), courtesy of
Dr. Andrew Conley of Agriculture and Agri-Food Canada,
London Ontario. Recombinant pCAMGate vectors were
transformed in Escherichia coli XL1-Blue using the Gene Pulser
II system (Bio-Rad Laboratories Inc., Hercules, CA, USA) and
PCR screening using gene-speciﬁc primers (Forward primer:
CGTTAGGTGTAGGTTTTGGTATGGATGGT, Reverse primer:
CCGGCAACAGGATTCAATCTTAA) was conducted to screen
for positive transformants containing the correct insert. Plasmid
DNA was isolated from positive colonies and transformed
into electro-competent Agrobacterium tumefaciens EHA105
cells. Electroporated A. tumefaciens cells were spread on yeast
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extract broth (YEB) plates containing 50 µg/ml kanamycin and
10 µg/ml rifampicin and incubated for 2 days at 28◦C.
Transient Expression in N. benthamiana
Plants
Suspensions of A. tumefaciens carrying Gp9 or A. tumefaciens
carrying the post-transcriptional gene silencing suppressor
p19 from Cymbidium ringspot virus (Silhavy et al., 2002),
were incubated overnight at 28◦C with shaking at 250 rpm
until an optical density at 600 nm (OD600) of 0.5–1.0 was
reached. Cultures were then centrifuged at 6000×g for 30 min
and resuspended to an OD600 of 1.0 in Gamborg’s solution
containing 3.2 g/l Gamborg’s B5 with vitamins, 20 g/l sucrose,
10 mM MES (pH 5.6), and 200 µM acetosyringone. Cultures
were then incubated at room temperature with gentle agitation
for 1 h. An equal volume of A. tumefaciens culture containing
Gp9 was combined with A. tumefaciens culture carrying p19
and Gamborg’s solution to give a total A. tumefaciens OD600
of approximately 0.67. These suspensions were used to inﬁltrate
7–8 week-old N. benthamiana plants grown in a growth
room under 16 h light/8 h dark conditions at 21–22◦C
with 55% humidity, and receiving roughly 100 µmol/photons
m−2s−1 of light. A 3 ml syringe was used to inﬁltrate
the A. tumefaciens suspensions through the stomata of the
abaxial leaf epidermis of N. benthamiana. After inﬁltration,
plants were returned to the growth chamber for up to
6 days.
Tissue Collection and Protein Extraction
Four biological replicates were used in all experiments and
consisted of four plants sampled as follows: two leaf disks/leaf
(7 mm diameter) were collected from three inﬁltrated leaves of
each plant and pooled. Tissue was ﬂash frozen in liquid nitrogen
and stored at −80◦C until use. For protein extraction, tissue was
homogenized twice in 30 s pulses using a TissueLyser (Qiagen,
Venlo, Netherlands) and TSP were extracted in 200 µl of plant
extraction buﬀer (PEB) containing 1X phosphate-buﬀered saline
(PBS), 0.1% (v/v) Tween-20, 2% (w/v) polyvinylpolypyrrolidone
(PVPP), 100mM ascorbic acid, 1 mM ethylenediaminetetraccetic
acid (EDTA), 1 mM of phenylmethanesulfonylﬂuoride (PMSF)
and 1 µg/ml leupeptin. TSP concentration for each sample
was determined using the Bradford assay (Bradford, 1976). For
electrophoresis under non-reducing conditions, protein samples
were stored in a 5% (w/v) SDS, 250 mg/ml glycerol, 0.1 mg/ml
bromophenol blue, 0.16 M Tris/HCl sample buﬀer (Seckler et al.,
1989) to better visualize protein trimerization. Samples were
frozen at −80◦C until use.
Western Blotting and Gel Staining
Pooled sample extracts and individual replicates were
immunodetected against a standard curve of known amounts of
puriﬁed Gp9-ELP to accurately quantify protein accumulation
levels. Samples were either boiled for ten minutes or not
boiled and loaded onto Bio-Rad Mini-Protean R© TGXTM
Precast 4–20% (w/v) polyacrylamide gradient gels. Separated
proteins were transferred to polyvinylidene diﬂuoride (PVDF)
membranes and blocked overnight in a 5% (w/v) skim milk
powder in TBS-T (Tris-buﬀered saline-Tween 20) blocking
solution. Membranes were incubated with a 1:5000 dilution of
mouse anti-c-Myc antibody (Genscript, A00864, Piscataway,
NJ, USA) or a 1:8000 dilution of rabbit polyclonal anti-Gp9
antibody (Kropinski et al., 2011). Membranes were washed
and incubated with a 1:5000 dilution of goat anti-mouse or
anti-rabbit secondary antibody conjugated with horseradish
peroxidase (HRP), and visualized with the GE Healthcare Life
Sciences (Little Chalfont, UK) ECL Prime Western Blotting
Detection Reagent. Recombinant protein was quantiﬁed by
image densitometry using Totallab TL100 software (Non-linear
Dynamics, Durham, NC, USA). For staining of separated
proteins, gels were washed for 5 min in water and stained
for 1 h with GelCodeTM Blue stain reagent (Thermo Fischer
Scientiﬁc, Waltham, MA, USA) at room temperature. Gels
were then destained using three 5-min washes with water and
imaged.
Protein Purification
Gp9-ELP and Gp9-HFBI proteins were puriﬁed using a c-Myc
tag puriﬁcation kit from MBL International Corporation MBL
(3305, Woburn, MA, USA) according to the manufacturer’s
instructions. Puriﬁed protein was stored at −80◦C until use. The
E. coli produced His6-Gp9 was puriﬁed as described by Waseh
et al. (2010).
Gp9 and Gp9-ELP Adherence to
S. Typhimurium
Salmonella enterica serovar Typhimurium (ATCC19585)
was purchased from the American Type Culture Collection
(Manassas, VA, USA) and grown under aerobic conditions at
37◦C on Lysogeny Broth (LB) agar plates. The strain used in the
adherence assay was transformed with the pWM1007 plasmid
(Miller et al., 2000) which expresses the green ﬂuorescence
protein (GFP) and grown on LB supplemented with 25 µg/ml
kanamycin.
Five hundred nanograms of the E. coli produced His6-Gp9,
BSA, or plant-produced Gp9-ELP were spotted onto hole punch
sized pieces of nitrocellulose membranes and then blocked for 1 h
in 5% (w/v) skim milk in PBS with 0.05% (v/v) Tween (PBS-T).
The membranes were then probed with 108 cfu/ml of GFP-
expressing S. Typhimurium in 5% skim milk PBS-T. The disks
were washed three times for 5 min in PBS-T and were then placed
onto LB agar plates with 25 µg/ml kanamycin and allowed to
grow at room temperature overnight, followed by growth at 37◦C
for 8 h. The disks were imaged with a FujiFilm (Tokyo, Japan)
FLA-5000 system using the 473 nm laser at 400V for excitation
and LPB (Y510) ﬁlter for emission. Fluorescence intensity was
measured using the MultiGauge version 3.0 software.
Animal Studies
Animal studies were carried out in accordance with the protocol
approved by the Animal Care and Use Committee at the
University of Alberta following the procedure described by
Waseh et al. (2010). Each group contained 5–8 SPF leghorn
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chickens (Poultry Research Facility, University of Alberta) that
were provided with feed and water ad libitum and were randomly
tested for the presence of Salmonella on the day of hatching by
plating cloacal swabs onto selective Oxoid Brilliance Salmonella
agar (Oxoid, ON, Canada). In all cases no Salmonella colonies
were observed after 24 h of incubation at 37◦C. Chickens were
orally gavaged with 300 µL PBS containing 107 colony forming
units (CFUs) of S. Typhimurium the next day and then gavaged
with 35 mg lyophilized and powdered leaves resuspended in
300 µl of PBS at 1, 18, and 42 h post-infection. The chickens
were culled at 47 h post-infection and the collected cecal contents
were serially diluted and plated onto Oxoid Brilliance Salmonella
agar. Salmonella CFU were counted after the agar plates were
incubated for 24 h at 37◦C.
Statistics
Minitab R© 17 statistical software (Minitab Ltd., Coventry, UK)
was used to perform statistical analysis on the Gp9 accumulation
data. A one-way analysis of variance (ANOVA) was performed
with a Tukey test on the mean Gp9 accumulation levels for each
day of the time course. P < 0.05 was considered signiﬁcant.
A two-tailed Student’s t-test was performed on the data from
the chicken experiment. P < 0.05 was once again considered
signiﬁcant.
RESULTS
Gp9 Transient Expression in
N. benthamiana
The Gp9 tailspike gene was cloned into pCaMGate expression
vectors (Pereira et al., 2014) targeting the ER, the ER fused with
an ELP tag (ER-ELP), the ER fused with aHFBI tag (ER-HFBI), or
the chloroplasts (Figure 1). Constructs were then agroinﬁltrated
along with the gene silencing suppressor, p19 (Silhavy et al.,
2002), into the leaves of N. benthamiana plants. Plants were
monitored over the course of 6 day(s) post-inﬁltration (dpi).
Young, upper leaves inﬁltrated with the ER-targeted constructs
turned a slight yellow–green color but otherwise the phenotypes
remained unchanged. Leaf tissue samples were collected from 3
to 6 dpi and analyzed for Gp9 accumulation via Western blot
using a c-Myc antibody speciﬁc for the C-terminal Myc peptide
found in all constructs (Figure 2A). Gp9 targeted to the ER was
faintly visible, running higher than predicted (Table 1), and no
bands were visible for the chloroplast-targeted Gp9. Conversely,
Gp9-ELP and Gp9-HFBI were readily detected, and faint bands
were observed for both the ELP and HFBI fused constructs
migrating above 150 kDa which could represent potential trimers.
Smaller bands ranging in size between 20 and 50 kDa were
also observed in the Gp9-ELP and Gp9-HFBI samples which
most likely correspond to Gp9 degradation products since they
are absent from the p19 negative control lane (Figure 2A).
Interestingly, when immunoblots were probed with an anti-Gp9-
antibody, a strong band slightly under 75 kDa was observed
for ER-targeted Gp9, and a somewhat fainter band was seen
in the chloroplast-targeted Gp9 (Figure 2B). Bands potentially
representing dimers and trimers were also observed for all
four proteins, as well as smaller bands that may represent Gp9
degradation products. It is interesting that the smaller bands
observed in the Gp9-ELP and Gp9-HFBI are of a diﬀerent
size when detected with the two antibodies. The protein band
migrating between 37.5 and 50 kDa may be a plant protein as it
appears faintly in the p19 lane, while the band running between
50 and 75 kDa may represent a degradation product of Gp9.
FIGURE 1 | Expression cassettes for Gp9 transient expression in N. benthamiana. (A) A schematic representing the gene constructs targeting the ER or the
chloroplasts. Two of the cassettes targeting the ER also contain sequences coding for an ELP or a HFBI tag with a linker (L). Expression and targeting elements
incorporated into the expression vectors are: the double-enhanced 35S cauliflower mosaic virus promoter (2X35S); tCUP translational enhancer from tobacco;
tobacco Pathogenesis-Related-1b signal peptide (PR1b) and the KDEL ER retrieval tetrapeptide; nopaline synthase terminator (nosT); and Xpress and c-Myc tags
for detection and purification. A sequence coding for the RuBisCo small subunit transit peptide (rbcS) was used for targeting to the chloroplasts. (B) A zoomed-out
schematic of the constructs in the T-DNA sequence. LB and RB are the left and right borders of the T-DNA sequence. nptII codes for neomycin phosphotransferase
conferring resistance to kanamycin, driven by a nopaline synthase promoter (nosP) and terminator (nosT). Schematic represents the same constructs in (A) with
different N-terminal fusions (NTFs) and C-terminal fusions (CTFs). Schematics are not to scale.
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FIGURE 2 | A time course of Gp9 accumulation levels in Nicotiana
benthamiana. (A) Immunoblots of TSP extracted from N. benthamiana leaf
tissue infiltrated with gp9 constructs targeting the ER, the chloroplasts, or the
ER fused to an ELP tag (ER-ELP) or fused to a hydrophobin tag (ER-HFBI).
Four plants were infiltrated with each construct. Tissue was sampled from
infiltrated leaves from 3 to 6 dpi. Equal volumes of TSP from each of the four
replicates were pooled, and 20 µg was loaded per well. Immunoblots were
probed with (A) an anti-c-Myc antibody or (B) an anti-Gp9 antibody. p19: TSP
from plants infiltrated with p19 serving as a negative control.
This band is present in all samples, and it may represent the
N-terminal portion of the protein detected with the Gp9-speciﬁc
antibody, while the smaller band running between 20 and 37 kDa
on the blot detected with the c-Myc antibody might represent
the C-terminal portion of the protein. The low abundance of
Gp9 on blots probed with the c-Myc antibody also imply that
the c-Myc tag is cleaved oﬀ Gp9, or is inaccessible to the
antibody.
Gp9 Accumulation in N. benthamiana
Since more protein was detected using the anti-Gp9-antibody,
this antibody was used to accurately quantify Gp9 accumulation
via densitometry analysis. For the purpose of protein
quantitation, only bands representing the full length Gp9
monomer were quantiﬁed. Immunoblots using individual
replicates revealed that Gp9 accumulation increases from the 3rd
dpi, peaks on day 4 or 5, and subsequently decreases (Figure 3).
ER-targeted Gp9 accumulated in signiﬁcantly higher amounts
than the other proteins reaching on average of 1.64 ± 0.09%
of TSP on day 5. When recombinant protein accumulation is
calculated in terms of micrograms of Gp9 per gram of FLW,
Gp9 accumulates to an average of 235.01 ± 21.12 µg/g of
TABLE 1 | Predicted molecular weights of Gp9 constructs.
Construct Predicted
full-length size
Predicted size
without c-Myc tag
Predicted size without
C-terminal fusions
ER 67 65.33 65.33
ER-ELP 78.47 76.8 65.33
ER-HFBI 74.78 73.63 65.33
Chloroplast 66.52 65.33 65.33
Values are in kiloDaltons (kDa).
FLW on day 4 (Figure 3B). The presence of either the ELP or
HFBI tag appears to signiﬁcantly decrease Gp9 accumulation
on 3–5 dpi (P < 0.05). Gp9-ELP accumulates on average to
0.98 ± 0.05% of TSP on day 5 or 135.86 ± 25.56 µg/g of FLW
on day 4, roughly 0.6 times or 1.7 times less, respectively, than
when unfused. The presence of the HFBI tag caused Gp9 to
accumulate in even lower amounts on average to 0.79 ± 0.09%
of TSP (0.48 times less) or 116.49 ± 16.29 µg/g of FLW (two
times less) on day 4. Gp9 accumulated signiﬁcantly less when
targeted to the chloroplasts compared to ER-targeted proteins
on days 4 and 5 (P < 0.05). Accumulation reached an average
of 0.21 ± 0.01% of TSP or 28.45 ± 1.65 µg/g of FLW on the
5th dpi.
Gp9-ELP Purification and
Characterization
Gp9 polypeptides are found in monomeric, dimeric, and trimeric
intermediates before forming the stable, native trimer (Benton
et al., 2002). The trimeric intermediate species or protrimer
consists of associated subunits which have not completely
folded forming a transient, less-stable precursor to the trimer
FIGURE 3 | Quantification of Gp9 accumulation in N. benthamiana
over 3, 4, 5, and 6 dpi. Quantification was performed on TSP extracts from
infiltrated N. benthamiana tissue using a standard curve of known amounts of
purified Gp9-ELP. Gp9 was targeted to the ER, the chloroplasts, or the ER
fused to an ELP tag (ER-ELP) or fused to a hydrophobin tag (ER-HFBI).
Immunoblots were probed with an anti-Gp9 antibody. Accumulation levels of
Gp9 are shown in µg per g of FLW. Error bars represent the standard error of
the mean value of four biological replicates. Treatments which do not share a
letter are significantly different (P < 0.05) as determined by a one way ANOVA
and the Tukey test.
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FIGURE 4 | Purified Gp9-ELP is found in higher molecular weight
protein complexes. Purified Gp9-ELP was electrophoresed under the
following conditions: in sample buffer containing DTT and heat-denatured by
boiling for 10 min, in sample buffer containing DTT with no heat denaturation,
or in sample buffer without DTT and no heat denaturation. The plant extract
containing Gp9-ELP was also loaded as a positive control in sample buffer
containing DTT and heat-denatured by boiling for 10 min. Twenty microliters
of extract from plants infiltrated with p19 were used as a negative control.
Gels were either coomassie stained (A) or immunodetected (B) using an
anti-c-Myc antibody.
(Goldenberg and King, 1982). We successfully puriﬁed Gp9-
ELP using a c-Myc-tag puriﬁcation kit (Figure 4A) and decided
to investigate if puriﬁed Gp9-ELP is present in either of these
states by avoiding complete denaturation (unheated sample)
and by avoiding reducing agents such as dithiothreitol (DTT)
in the sample buﬀer to keep the disulﬁde bonds oxidized
(unheated, no DTT). While most of the Gp9-ELP was found
in the monomeric form when it was reduced and denatured,
there was very little monomer present when heat denaturation
was omitted. Instead, an intense band was observed below
250 kDa, which corresponds to the expected size for the 215 kDa
trimer (Figures 4A,B). Higher banding was observed when
samples were electrophoresed under non-reducing conditions
(Figure 4B). Gp9 contains eight cysteine residues and has
disulﬁde bonds while existing as a protrimer, despite the fact
that all are reduced during conversion to the native trimeric state
(Robinson and King, 1997). Consequently, bands running above
250 kDa could represent the protrimer intermediate running
slower than the trimer. Generally, an oxidizing environment is
needed for trimer folding due to the presence of the disulﬁde
bonds in the protrimer, yet increasing concentrations of DTT
increases the conversion of protrimer to trimer (Robinson
and King, 1997). Even larger bands were visualized and could
represent higher-order multimers or aggregates (Speed et al.,
1997).
Our results suggest that Gp9 is present in the stable trimeric
form when puriﬁed and is expected to remain functional to some
degree.
Gp9-ELP Binding to S. Typhimurium
To determine if the plant produced Gp9 can bind to S.
Typhimurium, 500 ng of puriﬁed Gp9-ELP was spotted onto
a nitrocellulose membrane, blocked and then probed for 1 h
with 108 cfu/ml of GFP expressing S. Typhimurium. BSA
and E. coli-produced Gp9 were used as negative and positive
controls, respectively. Gp9-ELPwas able to bind S. Typhimurium
at similar levels as the E. coli-produced Gp9 as measured
by ﬂuorescence (Figure 5) suggesting that the plant-produced
protein is functional.
The Effect of Oral Administration of
Gp9-ELP on Salmonella Colonization
Due to the demonstrated binding activity of Gp9-ELP, we
investigated the eﬀects of orally administering plant tissue
containing Gp9-ELP on Salmonella colonization in chicks.
The chicks were orally gavaged with 35 mg of resuspended
plant tissue containing 7.7 µg Gp9-ELP 1, 18 and 42 h
after gavaging with S. Typhimurium. Chicks were culled
47 h after bacterial infection and the Salmonella CFU in the
cecal contents were enumerated (Figure 6). Gp9-ELP showed
approximately 1-log reduction in S. Typhimurium colonization
compared to the untreated control birds (P = 0.058). These
results are promising considering plant leaves were fed directly
to the birds without further puriﬁcation, and each dose
contained much less Gp9-ELP compared with the Waseh et al.
(2010) study where a dose consisted of 30 µg of puriﬁed
Gp9.
FIGURE 5 | S. Typhimurium binding activity to plant produced
Gp9-ELP. (A) The Escherichia coli produced His6-Gp9 (62 kDa) and the
plant-produced Gp9-ELP (82 kDa) both react with anti-Gp9 antibodies.
(B) Either 500 ng of His6-Gp9, BSA, or Gp9-ELP protein were spotted onto
nitrocellulose and then probed with 108 cfu/ml GFP-expressing S.
Typhimurium and allowed to grow overnight. Two biological replicates were
done, each with three technical replicates in each. One representative image
and densitometry analysis is shown.
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FIGURE 6 | Treatment of S. Typhimurium infected chickens with
Gp9-ELP. SPF leghorn chickens were orally gavaged with PBS or S.
Typhimurium as indicated. One hour later (and at 18 and 42 h), two of the
groups were orally gavaged with N. benthamiana extracts with or without
Gp9-ELP, while the control groups received PBS. Chickens were fed 7.7 µg of
Gp9-ELP per dose. Salmonella colonization levels of the chicken ceca were
determined 47 h post-infection. The median is shown for each group and
P-values were determined for the plant-fed groups in comparison to the S.
Typhimurium group. The arrow represents the detection limit of the
experiment.
DISCUSSION
This study demonstrated that the receptor binding domain of
the P22 bacteriophage tailspike protein, Gp9, could be transiently
expressed in N. benthamiana at reasonable levels and is able to
bind to S. Typhimurium. The results presented here suggest that
the correct choice of antibody for protein detection is essential
to accurately quantify recombinant protein accumulation. When
probing with an antibody speciﬁc to the C-terminal Myc tag,
Gp9 appeared to accumulate to the highest levels when fused
to an ELP or HFBI tag, supporting the hypothesis of this study
that these fusion tags would increase accumulation levels as
previously reported (Patel et al., 2007; Conley et al., 2009a;
Joensuu et al., 2010). These results were expected as ELP and
HFBI tags promote the formation and distribution of protein
bodies (PBs) which are thought to protect recombinant protein
from hydrolysis and protease cleavage (Conley et al., 2011;
Saberianfar et al., 2015).
However, probing with a Gp9-speciﬁc antibody gave
contrasting results. When the Gp9-speciﬁc antibody was used
for immunodetection, unfused ER-targeted Gp9 displayed
about 50% more accumulation than the ELP and HFBI fusions.
This result was unexpected, and suggests that Gp9 is stable
in N. benthamiana and the additional ELP or HFBI tags do
not increase protein stability further. Indeed, ELP tags have
negligible eﬀects on already high accumulating proteins such
as GFP (Conley et al., 2009a). It appears that the addition of
an ELP or HFBI tag actually decreases Gp9 accumulation when
targeted for retrieval to the ER ofN. benthamiana and this should
be investigated in future studies. These results also imply that
the c-Myc tag is partially cleaved or inaccessible causing us to
underestimate Gp9 accumulation levels when detecting with an
anti-c-Myc tag antibody. It is possible that the ELP andHFBI tags
protect the c-Myc tag from cleavage, possibly through protein
body formation, and therefore the fusion constructs were able to
be detected with the c-Myc antibody. However, when probing
with the Gp9 antibody the ER and chloroplast constructs produce
a slightly higher banding pattern than expected if the c-Myc is
indeed cleaved oﬀ (Figure 2; Table 1). It can be postulated then
that these proteins may fold into a conformation that makes
the c-Myc tag inaccessible. Regardless, as many recombinant
proteins are designed to have tags for easy detection, these results
are a cautionary note on the limits of short tags, and that perhaps
both N- and C-terminal tags might be used to improve chances of
accurate quantitation, while protein-speciﬁc antibodies are most
probably the best option if available. Our constructs also contain
an N-terminal Xpress tag (Figure 1), however, commercially
available antibodies have not detected any recombinant protein
in crude extracts (unpublished).
Gp9 also accumulated in the chloroplasts, but to a lower
level than when targeted to the secretory pathway. Generally,
chloroplast targeting is a promising strategy for increasing
recombinant protein accumulation (Hyunjong et al., 2006).
Nevertheless, some proteins do not accumulate well when
targeted to these organelles. For example, one study described
lower accumulation levels of zeolin, a chimeric storage protein,
when targeted to the chloroplasts compared to the ER.
A visualized degradation pattern of zeolin provided evidence for
protein degradation in the chloroplasts (Bellucci et al., 2007). On
the other hand, Oey et al. (2009) were able to express a phage
lysin protein in tobacco chloroplasts with accumulation levels
reaching 70% of TSP. This protein was produced by transforming
the plastid genome and the gene was codon-optimized for plastid
expression. The phage lytic protein was shown to be extremely
stable in the plastids, which is understandable as phages have
evolved substantial resistance to bacterial proteases. By analogy,
the Gp9 should be stable in the plastids, and therefore it is
possible that the protein is unable to eﬃciently translocate
into the chloroplasts. Therefore, future work could focus on
transforming the plastid genome of N. tabacum for high level,
stable expression of Gp9 without having to rely on chloroplast
protein import.
Like the full length Gp9, shortened versions lacking the
amino acid N-terminus domain maintain the stability and
enzymatic activity of the full length parent proteins (Miller et al.,
1998). To the best of our knowledge, this is the ﬁrst study to
transiently express this truncated protein in plants. Previously,
truncated tailspikes have been expressed in E. coli, isolated and
shown to reduce Salmonella colonization in the chicken GI
tract. It is believed that the tailspikes bind to Salmonella and
retard its motility and binding capability (Waseh et al., 2010).
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Consequently, plant-produced Gp9 has the potential to serve
as a therapeutic to control Salmonella. These proteins can
potentially be added to chicken or other livestock feed, reducing
contamination and reducing infections in humans. While the
plant produced Gp9 did not yield statistically signiﬁcant results
in the chicken experiment, the results are indeed promising.
We puriﬁed Gp9-ELP using a Myc column to show that
Gp9-ELP exists as a trimer and remains active by binding
to S. Typhimurium. However, it is still possible that the ELP
tag could alter Gp9 conformation in vivo, inﬂuencing activity
and future work could focus on unfused Gp9. In vitro, ELPs
have been reported to reduce protein activity compared to
non-fused proteins (Shamji et al., 2007; Kaldis et al., 2013).
It is possible that the physiological temperature of chickens
could inﬂuence the solubility of Gp9-ELP. This is because ELPs
undergo a reversible phase transition from soluble to insoluble
aggregates when heated past a certain transition temperature.
However, this transition temperature can be manipulated by
the altering the number and/or the residue composition of the
peptide repeats in order to adjust the solubility of Gp9-ELP,
thus allowing for better therapeutic eﬃcacy at physiological
temperatures (Hassouneh et al., 2012). Furthermore, it is likely
that the 1 log reduction in Salmonella colonization observed
in this study compared to the 2 log reduction in the Waseh
et al. (2010) study is due to the lower Gp9 dose administered
to the birds (30 µg of puriﬁed His6-Gp9 versus 7.7 µg Gp9-
ELP in 35 mg of lyophilized plant tissue per dose) as well as
the fact that the Gp9-ELP protein is contained within plant cells
and thus the chicken’s gut proteases need to digest through the
plant cell wall in order to release the protein. In the previous
study, it was shown that if the ﬁrst dose was delivered at 18 h
instead of 1 h post-infection, the beneﬁts of the treatment
were less. In our study, the protein would be released from
the plant tissue sometime after the treatment is administered,
so it is possible that this delay is partially responsible for
the lower reduction in infection. Future studies will compare
administration of higher levels of Gp9 protein and providing
the feed throughout the experiment in order to more closely
resemble the natural conditions in which this protein would be
used.
One of our goals in this study was to demonstrate that Gp9
could be directly administered while in minimally processed
plant tissue, without having to rely on taxing puriﬁcation
and formulation techniques. It can be postulated that puriﬁed
Gp9 may better reduce Salmonella colonization in chickens
as previously reported (Waseh et al., 2010). While a direct
comparison between puriﬁed and non-puriﬁed Gp9-ELP was
not done in this study, we have shown that wild type plant
tissue alone is not signiﬁcantly inﬂuencing S. Typhiumurium
colonization in chicks. Therefore, while future work should
mainly focus on increasing Gp9 accumulation inN. benthamiana,
this study serves as another successful example of engineering
plant factories for the production of a functional therapeutic.
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